IL-17A stimulates the expression of inflammatory cytokines via celecoxib-blocked prostaglandin in MC3T3-E1 cells

Archives of Oral Biology

Volumn 55, Issue 9, 2010, Pages 679-688

  Zhang, Fan ^a   Koyama, Yuki ^b   Sanuki, Rina ^b   Mitsui, Narihiro ^b   Suzuki, Naoto ^b   Kimura, Akemi ^b   Nakajima, Akira ^b   Shimizu, Noriyoshi ^b   Maeno, Masao ^b  

^a SHANDONG UNIVERSITY   (China)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Celecoxib; IL 17; Inflammatory cytokines; Osteoblasts

Indexed keywords

EID: 78149362100     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2010.06.003     Document Type: Article

References (47)

1. Krishnan V, Davidovitch Z. Cellular, molecular, and tissuelevel reactions to orthodontic force. Am J Orthod Dento/ac Orthop 2006; 129. 469.e1-32. (Pubitemid 43821225)
2. Lee KJ, Park YC, Yu HS, Choi SH, Yoo YJ. Effects of continuous and interrupted orthodontic force on interleukin-1ß and prostaglandin E2 production in gingival crevicular fluid. Am J Orthod Dento/ac Orthop 2004; 125: 168-77.
3. Tuncer BB, Özmerlç N, Tuncer C, Teoman I, Çakilci B, Yücel A, et al. Levels of interleukin-8 during tooth movement. Angle Orthod 2004; 75: 631-6.
4. Jäger A, Zhang D, Kawarizadeh A, Tolba R, Braumann B, Lossdörfer S, et al. Soluble cytokine receptor treatment in experimental orthodontic tooth movement in the rat. Eur J Orthod 2005; 27: 1-11. (Pubitemid 41219065)
5. Başaran G, Ozer T, Kaya FA, Hamamci O. Interleukins 2, 6, and 8 levels in human gingival sulcus during orthodontic treatment. Am J Orthod Dentofac Orthop 2006; 130: 7.e1-7.e6.
6. Bletsa A, Berggreen E, Brudvik P. Interleukin-1α and tumor necrosis factor-α expression during the early phases of orthodontic tooth movement in rats. Eur J Oral Sci 2006; 114: 423-9. (Pubitemid 44526681)
7. Karst M, Gorny G, Galvin RJ, Oursler MJ. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J Cell Physiol 2004; 200: 99-106. (Pubitemid 38720625)
8. Koyama Y, Mitsui N, Suzuki N, Yanagisawa M, Sanuki R, Isokawa K, et al. Effect of compressive force on the expression of inflammatory cytokines and their receptors in osteoblastic Saos-2 cells. Arch Oral Biol 2008; 53: 488-96.
9. Dudic A, Kiliaridis S, Mombelli A, Giannopoulou C. Composition changes in gingival crevicular fluid during orthodontic tooth movement: comparisons between tension and compression sides. Eur J Oral Sci 2006; 114: 416-22. (Pubitemid 44526680)
10. Ren Y, Vissink A. Cytokines in crevicular fluid and orthodontic tooth movement. Eur J Oral Sci 2008; 116: 89-97.
11. Gardner CR. Comparison of morphological effects of PGE2 and TGFbeta on osteoclastogenesis induced by RANKL in mouse bone marrow cell cultures. Cell Tissue Res 2007; 330: 111-21.
12. Kawashima M, Fujikawa Y, Itonaga I, Takita C, Tsumura H. The effect of selective cyclooxygenase-2 inhibitor on human osteoclast precursors to influence osteoclastogenesis in vitro. Mod Rheumatol 2009; 19: 192-8.
13. Sanuki R, Shionome C, Kuwabara A, Mitsui N, Koyama Y, Suzuki N, et al. Compressive force induces osteoclast differentiation via prostaglandin E2 production in MC3T3-E1 cells. Connect Tissue Res 2010; 51: 150-8.
14. Rouvier E, Luciani MF, Mattei MG, Denizot F, Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 1993; 150: 5445-56. (Pubitemid 23180658)
15. Yao Z, Timour M, Painter S, Fanslow W, Spriggs M. Complete nucleotide sequence of the mouse CTLA8 gene. Gene 1996; 168: 223-5. (Pubitemid 26068343)
16. Kramer JM, Gaffen SL. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 2007; 78: 1083-93.
17. Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol 2002; 71: 1-8. (Pubitemid 34062767)
18. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2005; 14: 155-74.
19. Latz E, Verma A, Visintin A, Gong M, Sirois CM, Klein DC, et al. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol 2007; 8: 772-9. (Pubitemid 46965353)
20. Kuestner R, Taft D, Haran A, Brandt C, Brender T, Lum K, et al. Identification of the IL-17 receptor related molecule, IL-17RC, as the receptor for IL-17F. J Immunol 2007; 179: 5462-73.
21. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003; 14: 155-74.
22. Lee J, Ho WH, Maruoka M, Corpuz RT, Baldwin DT, Foster JS, et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 2001; 276: 1660-4. (Pubitemid 32096603)
23. Venkatachalam K, Mummidi S, Cortez DM, Prabhu SD, Valente AJ, Chandrasekar B. Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2008; 294: H2078-87.
24. Chan FK. Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling. Cytokine 2007; 37: 101-7.
25. Van Bezooijen R, Farih-Sips HC, Papapoulos SE, Löwik CW. Interleukin-17: a new bone acting cytokine in vitro. J Bone Miner Res 1999; 9: 1513-21. (Pubitemid 29416677)
26. Bezerra MC, Carvalho JF, Prokopowitch AS, Pereira RM. RANK, RANKL and osteoprotegerin in arthritic bone loss. Braz J Med Biol Res 2005; 38: 161-70.
27. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999; 20: 345-57. (Pubitemid 30649812)
28. Katz Y, Nadiv O, Beer Y. Interleukin-17 enhances tumor necrosis factor α-induced synthesis of interleukins 1, 6, and 8 in skin and synovial fibroblasts: a possible role as a ''finetuning cytokine'' in inflammation processes. Arthritis Rheum 2001; 44: 2176-84.
29. Hwang SY, Kim JY, Kim KW, Park MK, Moon Y, Kim WU, et al. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaBand PI3-kinase/Aktdependent pathways. Arthritis Res 2004; 6: R120-8.
30. Takahashi K, Azuma T, Motohira H, Kinane DF, Kitetsu S. The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol 2005; 32: 369-74. (Pubitemid 40569599)
31. Tokuda H, Kanno Y, Ishisaki A, Takenaka M, Harada A, Kozawa O. Interleukin (IL)-17 enhances tumor necrosis factor-alpha-stimulated IL-6 synthesis via p38 mitogenactivated protein kinase in osteoblasts. J Cell Biochem 2004; 91: 1053-61.
32. Tokuda H, Kozawa O, Uematsu T. Interleukin (IL)-17 enhances prostaglandin F2α-stimulated IL-6 synthesis in osteoblasts. Prostaglandins Leukot Essent Fatty Acids 2002; 66: 427-33. (Pubitemid 34785774)
33. Mitsui N, Suzuki N, Maeno M, Mayahara K, Yanagisawa M, Otsuka K, et al. Optimal compressive force induces bone formation via increasing bone sialoprotein and prostaglandin E2 production appropriately. Life Sci 2005; 77: 3168-82. (Pubitemid 41433318)
34. Zhang F, Wang CL, Koyama Y, Mitsui N, Shionome C, Sanuki R, et al. Connective force stimulates the expression of IL-17s and their receptors in osteoblastic MC3T3-E1 cells. Connect Tissue Res 2010; 51: in press.
35. Sudo H, Kodama H, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983; 96: 191-8.
36. Watanabe Y, Namba A, Honda K, Aida Y, Matsumura H, Shimizu O, et al. IL-1β stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2. Connect Tissue Res 2009; 50: 186-93.
37. Kurokouchi K, Kambe F, Kikumori T, Sakai T, Sarkar D, Ishiguro N, et al. Effects of glucocorticoids on tumor necrosis factor α-dependent activation of nuclear factor κB and expression of the intercellular adhesion molecule 1 gene in osteoblast-like ROS17/2.8 cells. J Bone Miner Res 2000; 15: 1707-15. (Pubitemid 30666225)
38. Samoto H, Shimizu E, Matsuda-Honjyo Y, Saito R, Nakao S, Yamazaki M, et al. Prostaglandin E2 stimulates bone sialoprotein (BSP) expression through cAMP and fibroblast growth factor 2 response elements in the proximal promoter of the rat BSP gene. J Biol Chem 2003; 278: 28659-67. (Pubitemid 36935772)
39. Tanabe N, Maeno M, Suzuki N, Fujisaki K, Tanaka H, Ogiso B, et al. IL-1α stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts. Life Sci 2005; 77: 615-26. (Pubitemid 40726349)
40. Okada N, Kobayashi M, Mugikura K, Okamatsu Y, Hanazawa S, Kitano S, et al. Interleukin-6 production in human fibroblasts derived from periodontal tissues is differentially regulated by cytokines and a glucocorticoid. J Periodontol Res 1997; 32: 559-69. (Pubitemid 127522301)
41. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990; 145: 3297-303.
42. Rozen N, Ish-Shalom S, Rachmiel A, Stein H, Lewinson D. Interleukin-6 modulates trabecular and endochondral bone turnover in the nude mouse by stimulating osteoclast differentiation. Bone 2000; 26: 469-74. (Pubitemid 30204467)
43. Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 2003; 33: 28-37. (Pubitemid 36952685)
44. Hofbauer LC, Khosla C, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The role of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000; 15: 2-12. (Pubitemid 30026926)
45. Alhashimi N, Frithiof L, Brudvik P, Bakheit M. Orthodontic tooth movement and de novo synthesis of proinflammatory cytokines. Am J Orthod Dentofacial Orthop 2001; 119: 307-12. (Pubitemid 33601203)
46. Shoji M, Tanabe N, Mitsui N, Suzuki N, Takeichi O, Katono T, et al. Lipopolysaccharide enhances the production of nicotine-induced prostaglandin E2 via an increase in cyclooxygenase-2 expression in osteoblasts. Acta Biochim Biophys Sin 2007; 39: 163-72. (Pubitemid 46418278)
47. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999; 103: 1345-52. (Pubitemid 29218305)